Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Development of a first-of-a-kind complete solution for DNA methylation analysis | 2019 - 2019 | Innobooster
|
|
|
Development of a first-of-a-kind complete solution for DNA methylation analysis
Period
2019 - 2019
Region
Region Nordjylland Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
443.932 Budget
1.3 mill. Partners
MethylDetect ApS People
Methyl Detect ApS
Read more about the project
| |||
| Development of a long-acting dual GIP/GLP-2 tool compound for chronic PoC studies. | 2019 - 2022 | Industrial Researcher
|
|
|
Development of a long-acting dual GIP/GLP-2 tool compound for chronic PoC studies.
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
54.14 Invested
1.1 mill. Budget
2.0 mill. Partners
University of Copenhagen, Bainan Biotech ApS People
Bainan Biotech ApS
Read more about the project
| |||
| Development of a Prophylactic Vaccine Against Hepatitis C Virus | 2019 - 2020 | Innoexplorer
|
|
|
Development of a Prophylactic Vaccine Against Hepatitis C Virus
Period
2019 - 2020
Region
Region Hovedstaden Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
HVIDOVRE HOSPITAL People
HVIDOVRE HOSPITAL
Read more about the project
| |||
| Development of a therapeutic HER2 based vaccine against breast cancer | 2019 - 2022 | Industrial Researcher
|
|
|
Development of a therapeutic HER2 based vaccine against breast cancer
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
45.3 Invested
1.2 mill. Budget
2.7 mill. Partners
University of Copenhagen, AdaptVac ApS People
AdaptVac ApS
Read more about the project
| |||
| Development of a therapeutic vaccine targeting HER2 positive breast cancer | 2019 - 2020 | Innobooster
|
|
|
Development of a therapeutic vaccine targeting HER2 positive breast cancer
Period
2019 - 2020
Region
Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
808.500 Budget
2.5 mill. Partners
AdaptVac People
Aktiv
Read more about the project
| |||
| Development of new in vitro methods to predict oral absorption | 2019 - 2021 | Industrial Researcher
|
|
|
Development of new in vitro methods to predict oral absorption
Period
2019 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
53.91 Invested
828.000 Budget
1.5 mill. Partners
University of Copenhagen, LEO Pharma A/S People
LEO Pharma A/S
Read more about the project
| |||
| Development of once-weekly long acting dual agonist for treatment of osteoporosis | 2019 - 2021 | Innobooster
|
|
|
Development of once-weekly long acting dual agonist for treatment of osteoporosis
Period
2019 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
32.89 Invested
500.000 Budget
1.5 mill. Partners
Bainan Biotech People
Bainan Biotech ApS
Read more about the project
| |||
| Development of rapid detection kit for stratification of snakebites | 2019 - 2022 | Industrial Researcher
|
|
|
Development of rapid detection kit for stratification of snakebites
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
61.55 Invested
1.1 mill. Budget
1.7 mill. Partners
Technical University of Denmark, BIOPORTO DIAGNOSTICS A/S People
BIOPORTO DIAGNOSTICS A/S
Read more about the project
| |||
| Device for diagnosing and quantifying microvascular coronary artery disease | 2019 - 2020 | Innoexplorer
|
|
|
Device for diagnosing and quantifying microvascular coronary artery disease
Period
2019 - 2020
Region
Region Hovedstaden Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.4 mill. Budget
1.4 mill. Partners
RIGSHOSPITALET People
RIGSHOSPITALET
Read more about the project
| |||
| Device-tissue interactions in relation to shield-triggered pen devices | 2019 - 2022 | Industrial Researcher
|
|
|
Device-tissue interactions in relation to shield-triggered pen devices
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
40.3 Invested
1.1 mill. Budget
2.7 mill. Partners
University of Copenhagen, Novo Nordisk A/S People
Novo Nordisk A/S
Read more about the project
| |||
| Digital physio assessment and automated physio progression v2 | 2019 - 2019 | Innobooster
|
|
|
Digital physio assessment and automated physio progression v2
Period
2019 - 2019
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
286.605 Budget
868.500 Partners
Reach Acitve ApS People
REACH Active ApS
Read more about the project
| |||
| Dokumentering af iltmangel hos fostre under fødsler - En ny kontinuerlig og ikke-invasiv metode. | 2019 - 2020 | Innofounder
|
|
|
Dokumentering af iltmangel hos fostre under fødsler - En ny kontinuerlig og ikke-invasiv metode.
Period
2019 - 2020
Region
Region Hovedstaden Program
Innofounder Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
430.000 Budget
430.000 Partners
June Systems IVS People
June Systems IVS
Read more about the project
| |||
| Domain Adaptation and Semi-Supervised Learning for Automatic Speech Recognition in Medical Conversations | 2019 - 2022 | Industrial Researcher
|
|
|
Domain Adaptation and Semi-Supervised Learning for Automatic Speech Recognition in Medical Conversations
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
57.39 Invested
1.1 mill. Budget
1.9 mill. Partners
University of Copenhagen, Corti ApS People
Corti ApS
Read more about the project
| |||
| Drug-releasing silicone adhesives | 2019 - 2020 | Innoexplorer
|
|
|
Drug-releasing silicone adhesives
Period
2019 - 2020
Region
Region Hovedstaden Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.5 mill. Budget
1.5 mill. Partners
Danmarks Tekniske Universitet People
Danmarks Tekniske Universitet
Read more about the project
| |||
| Dual GLP1-leptin agonists for the treatment of obesity | 2019 - 2022 | Industrial Researcher
|
|
|
Dual GLP1-leptin agonists for the treatment of obesity
Period
2019 - 2022
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
50.04 Invested
1.1 mill. Budget
2.1 mill. Partners
University of Copenhagen, Gubra People
Gubra
Read more about the project
| |||